How powerful pharmaceutical companies shaped the response to the pandemic

Arun Kundnani meets Harris Gleckman
22 June 2022
Multi-media

Even in the midst of a global health emergency, companies treated the ill and the vulnerable as consumers and vaccines as commodities, setting prices and production rates that maximise profit.

 

During the pandemic, the World Health Organisation and governments took a back seat and power was centred on corporate interests. Health was viewed not as a right or a necessity, but as a product to be marketed and sold. Even in the midst of a global health emergency, companies treated the ill and the vulnerable as consumers and vaccines as commodities, setting prices and production rates that maximise profit. How has this happened and what, if any, are the alternatives?

Harris Gleckman is a Senior Fellow at the Centre for Sustainability and Governance at the University of Massachusetts, Boston and the Director of Benchmark Environmental Consulting. He was previously Head of the New York Office of the United Nations Conference on Trade and Development. Arun Kundnani is a TNI associate and author of The Muslims are Coming! Islamophobia, extremism, and the domestic War on Terror.

This video is part of a monthly series on the securitisation of health. Watch all videos here: https://www.youtube.com/playlist?list=PL6JRfkdlcGYWFO9hdjtk9ISAMbrHCHfqY